Laboratoires Euromedis Société anonyme

ENXTPA:ALEMG Stock Report

Market Cap: €12.6m

Laboratoires Euromedis Société anonyme Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Mathieu Roturier

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Does Laboratoires Euromedis Société anonyme (EPA:ALEMG) Have A Healthy Balance Sheet?

Nov 19
Does Laboratoires Euromedis Société anonyme (EPA:ALEMG) Have A Healthy Balance Sheet?

Little Excitement Around Laboratoires Euromedis Société anonyme's (EPA:ALEMG) Revenues

Aug 14
Little Excitement Around Laboratoires Euromedis Société anonyme's (EPA:ALEMG) Revenues

Health Check: How Prudently Does Euromedis Groupe (EPA:ALEMG) Use Debt?

Dec 12
Health Check: How Prudently Does Euromedis Groupe (EPA:ALEMG) Use Debt?

Investors Aren't Entirely Convinced By Euromedis Groupe's (EPA:ALEMG) Revenues

Jul 29
Investors Aren't Entirely Convinced By Euromedis Groupe's (EPA:ALEMG) Revenues

Health Check: How Prudently Does Euromedis Groupe (EPA:ALEMG) Use Debt?

Oct 05
Health Check: How Prudently Does Euromedis Groupe (EPA:ALEMG) Use Debt?

Euromedis Groupe (EPA:ALEMG) Might Have The Makings Of A Multi-Bagger

Jun 14
Euromedis Groupe (EPA:ALEMG) Might Have The Makings Of A Multi-Bagger

Under The Bonnet, Euromedis Groupe's (EPA:ALEMG) Returns Look Impressive

Oct 03
Under The Bonnet, Euromedis Groupe's (EPA:ALEMG) Returns Look Impressive

Euromedis Groupe's (EPA:ALEMG) Earnings Are Of Questionable Quality

Jun 12
Euromedis Groupe's (EPA:ALEMG) Earnings Are Of Questionable Quality

Has Euromedis Groupe (EPA:ALEMG) Got What It Takes To Become A Multi-Bagger?

Mar 18
Has Euromedis Groupe (EPA:ALEMG) Got What It Takes To Become A Multi-Bagger?

The Euromedis Groupe (EPA:ALEMG) Share Price Has Gained 173%, So Why Not Pay It Some Attention?

Feb 11
The Euromedis Groupe (EPA:ALEMG) Share Price Has Gained 173%, So Why Not Pay It Some Attention?

Euromedis Groupe's (EPA:ALEMG) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Jan 14
Euromedis Groupe's (EPA:ALEMG) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Is Euromedis Groupe (EPA:ALEMG) A Risky Investment?

Dec 19
Is Euromedis Groupe (EPA:ALEMG) A Risky Investment?

Calculating The Fair Value Of Euromedis Groupe (EPA:ALEMG)

Nov 22
Calculating The Fair Value Of Euromedis Groupe (EPA:ALEMG)

CEO Compensation Analysis

How has Mathieu Roturier's remuneration changed compared to Laboratoires Euromedis Société anonyme's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

€18m

Mar 31 2024n/an/a

€16m

Dec 31 2023n/an/a

€13m

Sep 30 2023n/an/a

€4m

Jun 30 2023n/an/a

-€6m

Mar 31 2023n/an/a

-€6m

Dec 31 2022n/an/a

-€6m

Sep 30 2022n/an/a

-€7m

Jun 30 2022n/an/a

-€8m

Mar 31 2022n/an/a

-€3m

Dec 31 2021n/an/a

€2m

Sep 30 2021n/an/a

€13m

Jun 30 2021n/an/a

€23m

Mar 31 2021n/an/a

€23m

Dec 31 2020€290k€97k

€23m

Sep 30 2020n/an/a

€12m

Jun 30 2020n/an/a

€419k

Mar 31 2020n/an/a

-€2m

Dec 31 2019€103k€97k

-€4m

Dec 31 2018€112k€144k

-€5m

Compensation vs Market: Insufficient data to establish whether Mathieu's total compensation is reasonable compared to companies of similar size in the French market.

Compensation vs Earnings: Mathieu's compensation has been consistent with company performance over the past year.

CEO

Mathieu Roturier

no data

Tenure

€289,518

Compensation

Mr. Mathieu Roturier serves as the Chief Executive Officer at Sa Laboratoires Euromedis. Mr. Roturier serves as a Manager at Sarl Laboratoires Euromedis Italie. He serves as the Chairman of the Board of Di...

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 08:51
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Laboratoires Euromedis Société anonyme is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stephanie LefebvreGilbert Dupont
Romain FreismuthPortzamparc BNP Paribas